Meine Merkliste  

Incorporation of mRNA in Lamellar Lipid Matrices for Parenteral Administration

Insertion of high molecular weight messenger RNA (mRNA) into lyotropic lipid phases as model systems for controlled release formulations for the mRNA was investigated. Low fractions of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) were used as an anchor to load the mRNA into a lamellar lipid matrix. Dispersions of zwitterionic lipid in the aqueous phase in the presence of increasing fractions of mRNA and cationic lipid were prepared, and the molecular organization was investigated as a function of mRNA and cationic lipid fraction. Insertion of both cationic lipid and mRNA was clearly proven from the physicochemical characteristics. The d-spacing of the lipid bilayers, as determined by small-angle X-ray scattering (SAXS) measurements, responded sensitively to the amount of inserted DOTAP and mRNA. A concise model of the insertion of the mRNA in the lipid matrices was derived, indicating that the mRNA was accommodated in the aqueous slab between lipid bilayers. Depending on the DOTAP and mRNA fraction, a...

Autoren:   Antje Ziller; Sara S. Nogueira; Eva Hühn; Sergio S. Funari; Gerald Brezesinski; Hermann Hartmann; Ugur Sahin; Heinrich Haas; Peter Langguth
Journal:   Molecular Pharmaceutics
Jahrgang:   2018
DOI:   10.1021/acs.molpharmaceut.7b01022
Erscheinungsdatum:   18.01.2018
Mehr über American Chemical Society Publications
Ihr Bowser ist nicht aktuell. Microsoft Internet Explorer 6.0 unterstützt einige Funktionen auf Chemie.DE nicht.